HedgeChatter

  • Home /
  • Tag Archives

IMMU

IMMUNOMEDICS IN COLLABORATION WITH ALGETA TO EVALUATE POTENTIAL OF EPRATUZUMAB CONJUGATED TO ALPHA-EMITTER THORIUM-227

[at noodls] – IMMUNOMEDICS,® INC….This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

January 28, 2013 Bystocknews , Comments Off on IMMUNOMEDICS IN COLLABORATION WITH ALGETA TO EVALUATE POTENTIAL OF EPRATUZUMAB CONJUGATED TO ALPHA-EMITTER THORIUM-227 read more

Algeta initiates new oncology research program to evaluate the potential of a Targeted Thorium Conjugate (TTC) based on Immunomedics’ anti-CD22 monoclonal antibody

[at noodls] – Algeta initiates new oncology research program to evaluate the potential of a Targeted Thorium Conjugate (TTC) based on Immunomedics’ anti-CD22 monoclonal antibody CD22 is a well-validated target for hematological … moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

January 28, 2013 Bystocknews , Comments Off on Algeta initiates new oncology research program to evaluate the potential of a Targeted Thorium Conjugate (TTC) based on Immunomedics’ anti-CD22 monoclonal antibody read more

IMMUNOMEDICS ANNOUNCES CONFERENCE CALL AND WEBCAST FOR SECOND QUARTER FISCAL 2013 FINANCIAL RESULTS

[at noodls] – IMMUNOMEDICS,® INC….This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

January 25, 2013 Bystocknews , Comments Off on IMMUNOMEDICS ANNOUNCES CONFERENCE CALL AND WEBCAST FOR SECOND QUARTER FISCAL 2013 FINANCIAL RESULTS read more

IMMUNOMEDICS ANNOUNCES U.S. PATENT FOR HEXAVALENT DOCK-AND-LOCKâ„¢ COMPLEXES

[at noodls] – IMMUNOMEDICS,® INC….This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

January 8, 2013 Bystocknews , Comments Off on IMMUNOMEDICS ANNOUNCES U.S. PATENT FOR HEXAVALENT DOCK-AND-LOCKâ„¢ COMPLEXES read more

Immunomedics Announces New Patent for Antibodies Targeting CD19

[at noodls] – IMMUNOMEDICS,® INC….This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

December 21, 2012 Bystocknews , Comments Off on Immunomedics Announces New Patent for Antibodies Targeting CD19 read more

Immunomedics Develops New Bispecific Antibodies That Exhibit Potent Anti-Lymphoma Activity

[at noodls] – IMMUNOMEDICS,® INC….This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

December 12, 2012 Bystocknews , Comments Off on Immunomedics Develops New Bispecific Antibodies That Exhibit Potent Anti-Lymphoma Activity read more

Immunomedics Provides Clinical Updates on Subcutaneous Injections of Veltuzumab in Autoimmune Disease and Cancer

[at noodls] – IMMUNOMEDICS,® INC….This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

December 11, 2012 Bystocknews , Comments Off on Immunomedics Provides Clinical Updates on Subcutaneous Injections of Veltuzumab in Autoimmune Disease and Cancer read more

Addition of Epratuzumab to Combination Chemotherapy May be Beneficial in Acute Lymphocytic Leukemia

[at noodls] – IMMUNOMEDICS,® INC….This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

December 10, 2012 Bystocknews , Comments Off on Addition of Epratuzumab to Combination Chemotherapy May be Beneficial in Acute Lymphocytic Leukemia read more

Epratuzumab’s B-Cell Modulation Effect Elucidated in Preclinical Study

[at noodls] – IMMUNOMEDICS,® INC….This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

December 10, 2012 Bystocknews , Comments Off on Epratuzumab’s B-Cell Modulation Effect Elucidated in Preclinical Study read more

Immunomedics to Present at Oppenheimer 23rd Annual Healthcare Conference

[at noodls] – IMMUNOMEDICS,® INC….This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

December 6, 2012 Bystocknews , Comments Off on Immunomedics to Present at Oppenheimer 23rd Annual Healthcare Conference read more